Overview
- Digemid mandated the nationwide withdrawal and destruction of the affected iron tablets, with Indecopi issuing the public alert through its Consumer Alerts System.
- The action applies exclusively to lot 2077104 of coated 300 mg tablets in boxes of 100 units under sanitary registration EN-05853 held by Laboratorios Portugal S.R.L.
- Regulators linked the decision to a critical nonconformity in dissolution testing that could undermine treatment for iron‑deficiency anemia.
- Consumers are instructed to check the lot number, stop using any matching product, and seek guidance from their pharmacy or Digemid at (01) 631 4300.
- Authorities said the product holder must coordinate the recall and inform pharmacies and health centers as part of ongoing market surveillance.